Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 May 7:9:2581-3.
doi: 10.2147/DDDT.S84301. eCollection 2015.

Update on the clinical utility of once-daily tacrolimus in the management of transplantation

Jane Revollo  1
Affiliations
Comment

Update on the clinical utility of once-daily tacrolimus in the management of transplantation

Jane Revollo. Drug Des Devel Ther. .
No abstract available

PubMed Disclaimer

Comment in

  • Authors' reply.
    Posadas Salas MA, Srinivas TR. Posadas Salas MA, et al. Drug Des Devel Ther. 2015;9:2584. Drug Des Devel Ther. 2015. PMID: 26201100 No abstract available.

Comment on

References

    1. Posadas Salas MA, Srinivas TR. Update on the clinical utility of once-daily tacrolimus in the management of transplantation. Drug Des Devel Ther. 2014;8:1183–1194. - PMC - PubMed
    1. Garnock-Jones KP. Tacrolimus prolonged release (Envarsus®): a review of its use in kidney and liver transplant recipients. Drugs. 2015;75(3):309–320. - PubMed
    1. Bunnapradist S, Ciechanowski K, West-Thielke P, et al. Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial. Am J Transplant. 2013;13(3):760–769. - PMC - PubMed
    1. Budde K, Bunnapradist S, Grinyo JM, et al. Novel once-daily extended-release tacrolimus (LCPT) vs twice-daily tacrolimus in de novo kidney transplants: one-year results of phase III, double-blind, randomized trial. Am J Transplant. 2014;14(12):2796–2806. - PubMed
    1. Krämer BK, Charpentier B, Bäckman L, et al. Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo transplantation: a randomized phase III study. Am J Transplant. 2010;10(12):2632–2643. - PubMed

MeSH terms